GBPL’s Protein Antibacterial Technology Platform (PATP) is built on extensive expertise in phage biology and naturally occurring antibacterial proteins, enabling identification and engineering of potent protein antibacterials.
Protein antibacterials being researched at GangaGen belong to two major classes.
Ribosomally synthesized protein toxins that kill closely related bacteria and can be engineered as targeted **antibacterial** agents.
Learn More
Bacteriophage‑encoded enzymes that cleave peptidoglycan and rapidly lyse target bacteria, including drug‑resistant strains.
Learn More
Powered by 